The short answer
Partly — and in most trials the part that comes back first is the part you use to check. In two of the three trials here that measured both, felt sleepiness was back at baseline within one or two long nights (not after one 10-hour night in Banks 2010), while sustained attention lagged in all three: after one 10-hour night (Banks), two (Pejovic 2013), or, for reaction speed, four 12-hour nights (Yamazaki 2021). The residue is small — about 1.4 (Pejovic) to 2.5 (Banks) extra lapses per 10-minute vigilance test. Take the weekend sleep. Don’t let “I feel fine” close the account.
Why this is here: the outcome these trials tracked most carefully, lapses on the psychomotor vigilance test (PVT), is sustained attention. The fit stops there: no trial here measured reasoning, code review or decisions, and none tested anyone at their job; every attention figure below is laboratory data.
What the long nights bought
Banks 2010 is the largest trial: 159 adults aged 22–45, of whom 142 had five nights at 4 hours in bed, then one recovery night randomised from 0 to 10 hours; 17 were rested controls. Each added hour removed about 1.38 lapses per test. The 10-hour group, who slept 8.96 hours, still averaged 5.6 lapses against 3.1 at baseline (p = 0.008) and rated themselves sleepier (p = 0.007). The authors’ linear projection for clearing lapses was 10.66 hours in bed, 95% interval 7.97 to 13.34 — “large”, they say. What did come back: a stay-awake test (p = 0.558 against baseline) and processing speed (symbol substitution), projected to meet rested controls at about 8 hours in bed. Its authors declared pharmaceutical, food, aviation and logistics ties, and one was the publishing journal’s paid editor-in-chief.
Most desk weeks are milder. Pejovic 2013 (DOI 10.1152/ajpendo.00301.2013) used six nights at 6 hours, then 10-hour nights, in 30 adults aged 18–34. After two of them, subjects were less sleepy than before the short week — 2.50 minutes slower to fall asleep in daytime nap tests (p < 0.01), lower on their own ratings (p = 0.04) — and the inflammatory marker IL-6 was back at baseline (p = 0.94). Lapses were 4.3 against 2.9 at baseline (p = 0.04), and no PVT measure improved from short week to recovery (p = 0.69 to 0.92). The paper’s text says the short week significantly worsened three PVT measures, its own Table 3 shows one at p < 0.05, and there was no control group.
Four nights at twelve hours
Yamazaki 2021 (DOI 10.1093/sleep/zsaa224) is a later cohort from the same Penn laboratory as Banks, not an independent replication. Of 83 adults aged 21–50, 41 had five 4-hour nights, then four with 12 hours in bed. Felt sleepiness and the stay-awake test differed from baseline only on the sleep-loss day: back after night one. PVT response speed was below baseline on every one of the four recovery days, while better than during the short week. They slept 10.4 hours the first night and 8.3 by the fourth, which, the authors argue, rules out too little recovery sleep.
I went looking for the size of that gap; the main text prints no means for any performance measure, only figures. There was no control arm. Although the abstract says lapses “failed to completely recover”, the Discussion concedes that post hoc tests for lapses “were not conducted in the formal analysis”; speed is the tested finding. I have not seen the supplement.
Where the lag may not apply
None of those trials analysed recovery by age, and their subjects were mostly in their twenties and thirties. The one study confined to middle-aged adults points the other way. Philip 2012 — found only as an abstract — put 18 men aged 46–55 through five 4-hour nights; the abstract reports alertness and performance back at baseline after a single 8-hour night, and gives no statistics. A recovery reported without statistics, in 18 men, is weak evidence of full recovery. Its abstract adds that subjects underestimated their own improvement: feeling ran behind the tests.
What else the trials show
Depner 2019 (DOI 10.1016/j.cub.2019.01.069) is the only trial here that let people choose their weekend. After a 5-hour work week, 14 adults slept 10.0 hours on Friday, 9.2 on Saturday — and 6.1 on Sunday, alarm fixed, against a baseline of 8.1 (p < 0.001). Net gain: about 1.1 hours, against what the authors call “the more than 12 h” lost. A tenth, at most. They woke about 3.5 to 3.9 hours later than usual, and on Monday their melatonin onset came about 1.7 hours later. What this cannot show: whether Monday’s thinking suffered — the trial measured no cognitive outcome — or whether a smaller shift does the same. One weekend; young, lean subjects.
This trial’s press headline — “No, researchers say” — came from its metabolic result: whole-body insulin sensitivity about 27% below baseline once the weekend group was back on short nights (one-tailed test, one outlier removed); the main paper reports no test against the group that never caught up, and p was 0.054 with body weight controlled. One Depner author declared fees from Kellogg, among others, outside the work.
On glucose, two trials disagree. Broussard 2016 (a letter; 19 lean young men): insulin sensitivity fell 23% after four short nights; two nights averaging 9.7 hours improved it and returned the disposition index to normal-sleep levels. The abstract of Ness 2019 (15 men) reports that index not recovered after two 10-hour nights (p = 0.01): two nights “may not be adequate”.
Funding: the five full-text trials (references 1–3, 5, 6) list government, foundation and fellowship grants and no industry sponsor — chiefly NIH, with NASA and the US Air Force (Banks), the Office of Naval Research as Yamazaki’s main funder, and the Department of Defense (Broussard); Pejovic’s is stated only as partially NIH-funded. Beyond the two disclosures above, none declared conflicts. Philip’s abstract page: “not an industry supported study”. Ness, and the consensus statement cited below: not retrieved.
Monday
One action: take the extra sleep at the front end — an earlier bedtime on Friday and Saturday, a wake time moved little — and early in the week, treat feeling rested as a reading from an instrument that can clear before attention does. Give work where a lapse means a missed defect a second check.
The bedtime half is inference: no trial I read compared earlier bedtime with later waking. Banks’ recovery nights were built that way (bed at 22:00 rather than 04:00, wake time unchanged). A co-author of the National Sleep Foundation’s 2023 consensus panel put the useful extension at one to two hours in a Harvard Gazette interview — from cardiometabolic associations, not cognition; the statement’s abstract says only that catch-up “may be beneficial”.
This does not apply if your weekdays are not short, and may not if you are nearer fifty than thirty. Nor does it cover the weekly habit: I have not read a trial that repeats the cycle and measures cognition. Naps are a separate mechanism with their own arithmetic. And which outcome a trial measures decides what it finds: in two of these three trials, the outcome you can feel read normal first.
About this article
Written by Drew Anton. Drew covers behaviour, sleep, and the compounds people take for both — doses, timing, and what the label does and does not tell you. Not a physician or research scientist — reads the primary literature closely and refuses to round up.
Medical review: None. NeuriFuel does not currently have a licensed clinician on the editorial team, and this article has not been medically reviewed. We state this rather than implying an authority we do not have. See our About page for our full methodology.
Sources: Eight papers and two secondary web pages. Five human laboratory trials are used at full-text level (references 1, 2, 3, 5 and 6; Yamazaki 2021 without its supplementary tables); three papers — Philip 2012, Ness 2019 and the National Sleep Foundation consensus statement — were read at abstract level only and are described that way wherever they are used. The press headline and the interview are marked as secondary in the reference list. Missing values are marked in the text and conflicting results are presented as conflicting. Funding could not be retrieved for Ness 2019 or for the consensus statement, and for Philip 2012 only the no-industry statement, not the grant funder; that is a gap, not a clean bill. Erratum checks on PubMed could not be run for the trials cited; where a publisher’s page was read, no correction notice was displayed.
Corrections: Found an error? Write to hello@neurifuel.com with a source and we will fix it and log the correction.
Last updated: 21 October 2026
References
- Banks S, Van Dongen HPA, Maislin G, Dinges DF (2010). Neurobehavioral dynamics following chronic sleep restriction: dose-response effects of one night for recovery. Sleep 33(8):1013–1026. DOI 10.1093/sleep/33.8.1013 · PMID 20815182. Read: full text including supplement tables. Funding: NIH, NSBRI via NASA, US Air Force Office of Scientific Research, University of South Australia fellowship; “not an industry supported study”. Disclosures: Dinges — research support or consulting from Cephalon, Merck, Actelion, Eli Lilly, Mars Inc., Sanofi-Aventis, Somaxon, and paid as Editor-in-Chief of Sleep; Van Dongen — support from Boeing and Continental Airlines, speaking for Clayton Sleep Institute, consulting for FedEx; Maislin — directs a statistical consulting firm contracting with industry and academia; Banks — none.
- Pejovic S, Basta M, Vgontzas AN, Kritikou I, Shaffer ML, Tsaoussoglou M, Stiffler D, Stefanakis Z, Bixler EO, Chrousos GP (2013). Effects of recovery sleep after one work week of mild sleep restriction on interleukin-6 and cortisol secretion and daytime sleepiness and performance. Am J Physiol Endocrinol Metab 305(7):E890–E896. DOI 10.1152/ajpendo.00301.2013 · PMID 23941878. Read: full text (figures not legible). Funding: partially NIH; no conflicts declared.
- Yamazaki EM, Antler CA, Lasek CR, Goel N (2021; online 6 Nov 2020). Residual, differential neurobehavioral deficits linger after multiple recovery nights following chronic sleep restriction or acute total sleep deprivation. Sleep 44(4):zsaa224. DOI 10.1093/sleep/zsaa224 · PMID 33274389. Read: full text; supplementary tables not seen. Funding: US Office of Naval Research (primary), NASA, NIH; conflicts: none declared.
- Philip P, Sagaspe P, Prague M, Tassi P, Capelli A, Bioulac B, Commenges D, Taillard J (2012). Acute versus chronic partial sleep deprivation in middle-aged people: differential effect on performance and sleepiness. Sleep 35(7):997–1002. DOI 10.5665/sleep.1968 · PMID 22754046. Read: abstract only. “Not an industry supported study”; no financial conflicts indicated; grant funding not retrieved.
- Depner CM, Melanson EL, Eckel RH, Snell-Bergeon JK, Perreault L, Bergman BC, Higgins JA, Guerin MK, Stothard ER, Morton SJ, Wright KP Jr (2019). Ad libitum weekend recovery sleep fails to prevent metabolic dysregulation during a repeating pattern of insufficient sleep and weekend recovery sleep. Curr Biol 29(6):957–967.e4. DOI 10.1016/j.cub.2019.01.069 · PMID 30827911. Read: full text including methods; supplement not opened. Funding: NIH, Sleep Research Society Foundation. Disclosures: Wright — fees from NIH advisory boards, Torvec, Circadian Therapeutics and Kellogg Company, and research support from NIH, Office of Naval Research, PAC-12 and Somalogic, declared as outside the submitted work; other ten authors none.
- Broussard JL, Wroblewski K, Kilkus JM, Tasali E (2016). Two nights of recovery sleep reverses the effects of short-term sleep restriction on diabetes risk. Diabetes Care 39(3):e40–e41 (letter). DOI 10.2337/dc15-2214 · PMID 26786578. Read: full text (figure values not legible). Funding: NIH institutes, US Department of Defense, Branco Weiss Fellowship; no relevant conflicts reported.
- Ness KM, Strayer SM, Nahmod NG, Chang A-M, Buxton OM, Shearer GC (2019). Two nights of recovery sleep restores the dynamic lipemic response, but not the reduction of insulin sensitivity, induced by five nights of sleep restriction. Am J Physiol Regul Integr Comp Physiol 316(6):R697–R703. DOI 10.1152/ajpregu.00336.2018 · PMID 30892916. Read: abstract only. Funding and conflicts: not retrieved.
- Sletten TL, Weaver MD, Foster RG, Gozal D, Klerman EB, Rajaratnam SMW, Roenneberg T, Takahashi JS, Turek FW, Vitiello MV, Young MW, Czeisler CA (2023). The importance of sleep regularity: a consensus statement of the National Sleep Foundation sleep timing and variability panel. Sleep Health 9(6):801–820. DOI 10.1016/j.sleh.2023.07.016. Read: abstract only. Funding and panel disclosures: not retrieved; the panel was convened by the National Sleep Foundation, which publishes the journal.
- Harvard Gazette, September 2023. Interview with a co-author of reference 8 (source of the “one to two hours” figure). Read: secondary level — the interview page itself, opened at source.
- ScienceDaily, 28 February 2019. “Does extra sleep on the weekends repay your sleep debt? No, researchers say.” Cell Press release on reference 5. Read: secondary level — the release page, opened at source.

